Identification of complex co-occurring symptom burden in persons with cancer through multisite implementation of health-related social needs assessment in community oncology settings.

Authors

null

Puneeth Indurlal

McKesson, The US Oncology Network, The Woodlands, TX

Puneeth Indurlal , Jody S. Garey , Abigail Traul , Misty Dawn Chicchirichi , Taylor Adams , Lalan S. Wilfong , Dana Weber , Jessica louise neeb , Evan Osborne , Ishwaria M. Subbiah

Organizations

McKesson, The US Oncology Network, The Woodlands, TX, The US Oncology Network, The Woodlands, TX, Willamette Valley Cancer Institute and Research Center, Eugene, OR, Shenandoah Oncology, Winchester, VA, Ontada, Las Colinas, TX, McKesson, The US Oncology Network, Greenwood, IN, McKesson Specialty Health, The US Oncology Network, The Woodlands, TX, Sarah Cannon Research Institute (SCRI), SCRI Oncology Partners, The US Oncology Network, Nashville, TN

Research Funding

No funding received

Background: Health related social needs (HRSN) impact cancer outcomes and patient experience, but their integration into routine cancer care is highly variable. To expand the implementation-centered evidence base for effective HRSN assessments, we studied a scalable HRSN screening tool to identify distress and complex symptom burden in patients with cancer. Methods: We prospectively tracked HRSN screenings (using the National Comprehensive Cancer Network [NCCN] Distress Thermometer [DT]) of patients at varying points during their cancer care between 07/2023-12/2023 at seven multi-site community oncology practices within the US Oncology Network. DT responses were used to evaluate the positive finding rate, types of distress reported, and correlations between distress areas and concerns reported. Results: Overall, 219,720 unique patients with cancer received 269,666 HRSN screenings using the NCCN DT; 27% had a distress score ≥1 and 38.5% reported a concern (of whom, 58.2% reported >1). Co-occurring concerns that were most correlated (Pearson correlation coefficient) were emotional & practical concerns in 49% of screenings, physical & practical 44%, emotional & social 37% and social & practical concerns 36%. Emotional symptoms most frequently reported together were sadness/depression + worry/anxiety 47%, loss of interest + sadness/depression 44%, and loneliness & sadness/depression 38.5%. Regarding complex symptom burden, the physical and psychosocial symptoms that were most correlated were fatigue & sleep 43%, pain & fatigue 40%, pain & sleep 38%, anxiety/worry & fatigue 37%, anxiety/worry & sleep 36%. Fatigue and pain, the two most frequently reported concerns were strongly correlated with emotional and practical concerns like sleep, worry or anxiety, memory or concentration, loss or change of physical abilities, sadness or depression, loss of interest or enjoyment, changes in eating, ability to take care of self, feelings of worthlessness or being a burden, etc. Concerns with the strongest correlations are reported in the table. Conclusions: Distress and its components impact multiple cancer outcomes making their rapid identification and consequent action key to high-quality cancer care. The findings highlight the NCCN DT as a scalable approach to integrate HRSN screening and to identify complex symptom burden in the real-world practice.

Co-occurring physical and psychosocial concerns.

Concern 1Concern 2Correlationr
Sadness or depressionWorry or anxiety47.3%0.5
Loss of interest or enjoymentSadness or depression44.3%0.4
FatigueSleep42.5%0.4
PainFatigue40.0%0.4
LonelinessSadness or depression38.5%0.4
PainSleep37.8%0.4
Worry or anxietyFatigue36.7%0.4
Worry or anxietySleep36.1%0.4
Taking care of myselfTaking care of others35.9%0.4

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2024 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Palliative and Supportive Care

Sub Track

Prospective Risk Assessment and Reduction

Citation

JCO Oncol Pract 20, 2024 (suppl 10; abstr 306)

DOI

10.1200/OP.2024.20.10_suppl.306

Abstract #

306

Poster Bd #

F20

Abstract Disclosures

Similar Abstracts

First Author: Valerie Pracilio Csik

First Author: Desiree Rachel Azizoddin

Abstract

2023 ASCO Quality Care Symposium

Do OCM-related increases in screening for depression and pain improve patient-reported symptoms?

First Author: Sean McClellan

Abstract

2021 ASCO Annual Meeting

Depression, chronic pain, and high-impact chronic pain among cancer survivors.

First Author: Nosayaba Osazuwa-Peters